the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

Launched by CHINESE PULMONARY VASCULAR DISEASE RESEARCH GROUP · Feb 11, 2014

Keywords

ClinConnect Summary

This clinical trial is studying how a special exercise test, called the cardiopulmonary exercise test, can help doctors understand the condition of patients with pulmonary hypertension. Pulmonary hypertension is a serious condition that affects the blood vessels in the lungs and can lead to shortness of breath and fatigue. The trial will look at how patients respond to medical treatment or a procedure called balloon pulmonary angioplasty, which can help open up blocked blood vessels in the lungs.

To participate in this study, individuals aged 18 to 65 who have specific types of pulmonary hypertension, including those caused by schistosomiasis or chronic blood clots in the lungs, may be eligible. However, people with certain serious conditions, like severe bleeding from the lungs or those who can’t perform the exercise test due to other health issues, cannot join. Participants can expect to undergo the exercise test before and after their treatment, helping researchers learn more about the effectiveness of these treatments in improving their health. This trial aims to gather valuable information to help improve care for those living with pulmonary hypertension.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • pulmonary arterial hypertension;( WHO1)
• • chronic thromboembolic pulmonary hypertension;
• • pulmonary arterial hypertension due to other cause;
• Exclusion Criteria:
• • massive hemoptysis;
• • unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
• • recent recurrent syncope;
• • pulmonary hypertension due to hypoxia;
• • pulmonary hypertension due to left heart diseases.